These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
197 related items for PubMed ID: 1311035
21. Monitoring liver tumor therapy with [18F]FDG positron emission tomography. Nagata Y, Yamamoto K, Hiraoka M, Abe M, Takahashi M, Akuta K, Nishimura Y, Jo S, Masunaga S, Kubo S. J Comput Assist Tomogr; 1990; 14(3):370-4. PubMed ID: 2335602 [Abstract] [Full Text] [Related]
22. Errors introduced by tissue heterogeneity in estimation of local cerebral glucose utilization with current kinetic models of the [18F]fluorodeoxyglucose method. Schmidt K, Lucignani G, Moresco RM, Rizzo G, Gilardi MC, Messa C, Colombo F, Fazio F, Sokoloff L. J Cereb Blood Flow Metab; 1992 Sep; 12(5):823-34. PubMed ID: 1506447 [Abstract] [Full Text] [Related]
23. Limited value of 18F-2-deoxyglucose positron emission tomography to detect hepatocellular carcinoma in hepatitis B virus carriers. Jeng LB, Changlai SP, Shen YY, Lin CC, Tsai CH, Kao CH. Hepatogastroenterology; 2003 Sep; 50(54):2154-6. PubMed ID: 14696485 [Abstract] [Full Text] [Related]
24. FDG transport and phosphorylation in human gliomas measured with dynamic PET. Herholz K, Rudolf J, Heiss WD. J Neurooncol; 1992 Feb; 12(2):159-65. PubMed ID: 1560262 [Abstract] [Full Text] [Related]
25. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose. Heiss WD, Pawlik G, Herholz K, Wagner R, Göldner H, Wienhard K. J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929 [Abstract] [Full Text] [Related]
26. [Mechanism of lipiodol accumulation and retention in hepatic tumors--analysis in cases of simple lipiodol injection]. Matsui O, Takashima T, Kadoya M, Kitagawa K, Hirose J, Kameyama T, Choutou S, Miyata S. Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Nov 25; 47(11):1395-404. PubMed ID: 2833717 [No Abstract] [Full Text] [Related]
27. PET imaging of hepatocellular carcinoma with 2-deoxy-2[18F]fluoro-D-glucose, 6-deoxy-6[18F] fluoro-D-glucose, [1-11C]-acetate and [N-methyl-11C]-choline. Salem N, Kuang Y, Wang F, Maclennan GT, Lee Z. Q J Nucl Med Mol Imaging; 2009 Apr 25; 53(2):144-56. PubMed ID: 19039303 [Abstract] [Full Text] [Related]
29. Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Shiomi S, Nishiguchi S, Ishizu H, Iwata Y, Sasaki N, Tamori A, Habu D, Takeda T, Kubo S, Ochi H. Am J Gastroenterol; 2001 Jun 25; 96(6):1877-80. PubMed ID: 11419843 [Abstract] [Full Text] [Related]
30. Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Sugawara Y, Zasadny KR, Grossman HB, Francis IR, Clarke MF, Wahl RL. Radiology; 1999 Apr 25; 211(1):249-56. PubMed ID: 10189480 [Abstract] [Full Text] [Related]
31. [Embolization of the hepatic artery in the treatment of malignant tumors of the liver]. Granov AM, Tarazov PG, Ryzhkov VK, Noskov AA, Polysalov VN, Derkach VIu, Dmitrieva IA, Gapchenko EM. Khirurgiia (Mosk); 1991 Apr 25; (4):80-6. PubMed ID: 1648150 [Abstract] [Full Text] [Related]
32. Analysis of kinetic rate constants in [18F]fluorodeoxyglucose model using a least square fitting package SALS (statistical analysis with least squares). Uehara S, Kuwabara Y, Ichiya Y, Otsuka M, Ayabe Y, Miyake Y, Masuda K, Yoshimura A. Radioisotopes; 1987 Dec 25; 36(12):653-6. PubMed ID: 3502293 [Abstract] [Full Text] [Related]
33. [Kinetics of glucose metabolism in central neurocytomas]. Shioya H, Mineura K, Sasajima T, Kowada M, Iida H, Ogawa T, Hatazawa J, Uemura K. No To Shinkei; 1995 Oct 25; 47(10):981-7. PubMed ID: 7577144 [Abstract] [Full Text] [Related]
34. [Longitudinal analysis of glucose metabolism in recurrent meningioma]. Shioya H, Mineura K, Sasajima T, Kowada M, Iida H, Ogawa T, Hatazawa J, Uemura K. No To Shinkei; 1994 Nov 25; 46(11):1088-93. PubMed ID: 7873283 [Abstract] [Full Text] [Related]
35. Effect of selecting a fixed dephosphorylation rate on the estimation of rate constants and rCMRGlu from dynamic [18F] fluorodeoxyglucose/PET data. Dhawan V, Moeller JR, Strother SC, Evans AC, Rottenberg DA. J Nucl Med; 1989 Sep 25; 30(9):1483-8. PubMed ID: 2788721 [Abstract] [Full Text] [Related]
38. FDG-PET evaluation of therapeutic effects on VX2 liver tumor. Oya N, Nagata Y, Tamaki N, Takagi T, Murata R, Magata Y, Abe M, Konishi J. J Nucl Med; 1996 Feb 25; 37(2):296-302. PubMed ID: 8667065 [Abstract] [Full Text] [Related]
39. Effect of vascular activity in the determination of rate constants for the uptake of 18F-labeled 2-fluoro-2-deoxy-D-glucose: error analysis and normal values in older subjects. Evans AC, Diksic M, Yamamoto YL, Kato A, Dagher A, Redies C, Hakim A. J Cereb Blood Flow Metab; 1986 Dec 25; 6(6):724-38. PubMed ID: 3491827 [Abstract] [Full Text] [Related]
40. Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions. Wienhard K, Pawlik G, Nebeling B, Rudolf J, Fink G, Hamacher K, Stöcklin G, Heiss WD. J Cereb Blood Flow Metab; 1991 May 25; 11(3):485-91. PubMed ID: 2016357 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]